October 29, 2015 9:45am

Dr. Smith joins with over 30 years of experience in cellular therapeutics, during which time he served in various leadership roles in Research and Development, Manufacturing and Quality.

Most recently, he was Vice President of Research & Development and Cellular Therapeutics at LifeNet Health, an organ procurement organization and tissue bank, and its wholly owned subsidiary, The Institute of Regenerative Medicine, a global research center focused on innovations in cellular therapies and tissue engineering.

Previously, Dr. Smith served as a consultant to the cell therapy industry, contributing to over 25 successful FDA regulatory submissions for cell therapy products and devices. He also served as President and Chief Executive Officer of Cognate BioServices, Inc., a contract service provider performing R&D and contract manufacturing for clients developing cellular therapies in regenerative medicine for cancer, immunotherapy, cardiovascular and neurological applications. Previously, he was the Chief Operating Officer and Senior Vice President of Research & Development at Osiris Therapeutics, where he created clinical processes and systems to deliver cell and gene therapies for hematopoietic, cardiovascular, immunotherapy and orthopedic applications.

Earlier in his career, Dr. Smith led R&D functions for Aastrom Biosciences, Inc. (now Vericel Corporation), Geneic Sciences, Inc. and Baxter Healthcare Corporation, Immunotherapy Division.

Dr. Smith is an Adjunct Professor in the Department of Biology and Molecular Cell Biology at Eastern Virginia Medical School and has previously held adjunct professorships at California State University Long Beach and Utah State University. Dr. Smith earned his Bachelor of Science in Chemistry at Southern Utah State College and his doctorate in Biochemistry at Utah State University.